1 result(s) for
|PI Name||Protocol #||Title|
|Craig Okada||STUDY00017796||A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and CHP (R-CHP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma|
You may also qualify for Phase 1 Program trials.
For more information: